Definium Therapeutics (DFTX) Return on Assets (2022 - 2026)
Definium Therapeutics (DFTX) posted quarterly Return on Assets of 1.45% for Q1 2026, down 144.0% year-over-year from 3.29% in Q1 2025, and down 1723.05% quarter-over-quarter from 0.08% in Q4 2025.
Definium Therapeutics (DFTX) Return on Assets (2022 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has reported Return on Assets for 5 consecutive years, with 1.45% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Assets fell 144.0% year-over-year to 1.45%; the TTM figure through Mar 2026 stood at 1.45% (down 144.0% YoY), while the FY2025 annual figure was 0.84%, down 64.0% from the prior year.
- Return on Assets fell to 1.45% in Q1 2026 per DFTX's latest filing, from 0.08% in the prior quarter.
- Across five years, Return on Assets topped out at 0.0% in Q3 2022 and bottomed at 1.45% in Q1 2026.
- Historically, Return on Assets has averaged 0.1% across 5 years, with a median of 0.0% in 2022.
- Annual changes were most pronounced in 2023 — Return on Assets changed 0 bps — and 2026, when it sank 144 bps.
- Definium Therapeutics' Return on Assets stood at 0.0% in 2022, then sank by 79 bps to 0.01% in 2023, then soared by 55 bps to 0.0% in 2024, then slumped by 2507 bps to 0.08% in 2025, then tumbled by 1723 bps to 1.45% in 2026.
- Business Quant data shows DFTX's Return on Assets at 1.45% in Q1 2026, 0.08% in Q4 2025, and 0.11% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.01% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Definium Therapeutics | 4.72 Bn | 4.72 Bn | - | -0.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.77% |
| Mar 31, 2026 | -1.45% |
| Dec 31, 2025 | -0.08% |
| Sep 30, 2025 | -0.11% |
| Jun 30, 2025 | -0.10% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |